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limitations and participation restrictions. More effort is needed to
improve care and research in this ﬁeld.
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Purpose: Although guidelines exist for the management of hip and
knee osteoarthritis (OA), little is known about how treatment use may
vary across health care settings, particularly in the United States (U.S.).
This study compared clinical characteristics and treatment use patterns
among patients with hip and knee OA in ten Family and Internal
Medicine clinics in one healthcare system, which varied in patient panel
size and represented both urban and rural settings.
Methods: Baseline data were obtained from an ongoing randomized
clinical trial of Patient and Provider Interventions for Managing
Osteoarthritis in Primary Care in the Duke University Healthcare Sys-
tem. Participants (n ¼ 488; 21–57 per clinic) had hip and / or knee OA,
were overweight, and were not meeting physical activity recom-
mendations. Clinical characteristics included the Western Ontario and
McMaster University Osteoarthritis Index (WOMAC) scale, self-reported
duration of arthritis symptoms, and diagnoses of hip and / or knee OA.
Self-reported OA treatment use included: current use of pain medi-
cations for OA (yes /no), ever having received physical therapy for knee /
hip OA (yes / no), ever having used a knee brace (yes / no), ever having a
knee joint injection (yes / no); the latter two questions were only asked
for patients with diagnoses of knee OA. For all measures we computed
means and standard deviations or proportions for each clinic.
Results: Clinical characteristics of patients varied considerably across
study sites.MeanWOMAC scores ranged from35.0 (SD¼ 16.1) to 44.1 (SD
¼ 15.0) and themean duration of arthritis symptoms ranged from 8.2 (SD
¼ 9.3) to 13.9 (SD ¼ 12.7) years. Most patients at each clinic had diag-
noses of knee OA (90%-100%), but the proportion with hip OA diagnoses
varied from 26%-68% across clinics; 23%-61% had both diagnoses. Most
patients at each clinic were currently using pain medications to treat
their OA (73%-88%). However, use of other treatments was lower and
varied more substantially across clinics. In seven of the clinics, less than
half of patients had ever received physical therapy for knee OA; pro-
portions ranged from 25%-64% across clinics. Physical therapy for hip OA
was even less common (0%-60%). Knee brace use (any type) ranged from
40%-64%, but use of braces with metal supports was much lesscommon
(0%-40%). Knee injections were reported by 43%-74% of patients.
Conclusions: The heterogeneity of patient characteristics across clinics
in this study illustrates the importance of including multiple and
diverse sites in clinical and health services trials for knee and hip OA.
These data on OA treatment use across different clinics are some of the
ﬁrst to be reported in the U.S. and show considerable variation, par-
ticularly in the use of non-pharmacological therapies. Despite the rel-
atively long average duration of symptoms in these patients, physical
therapy use was very low in many of the clinics. This represents one
important area for improvement and standardization in the practice of
OA management, particularly knee OA, since physical therapy is an
evidence-based and recommended treatment component.
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WAITING FOR HIP REPLACEMENT: PATIENTS’ EXPERIENCES OF TIME
R. Gooberman-Hill, J. Horwood, E. Johnson. Univ. of Bristol, Bristol,
United Kingdom
Purpose: Numbers of hip replacement procedures are on the increase
globally. In the UK, over 76,000 now take place annually for patients
who have been living with pain and disability associated with osteo-
arthritis. The time waiting for surgery is known to have an impact on
pain and functional ability, and processes within healthcare systems
often strive to reduce waiting times. Within the UK’s National Health
Service, many patients have their hip replacement well within the 18
week window stipulated by previous policies, but wait for surgery may
be complicated by cancellations and delay. Although reduction inwaiting times is often heralded as a positive move in healthcare pro-
vision and the clock is seen as paramount in service planning, it is not
known how patients awaiting view and experience passage of time in
the lead-up to their surgery. This information has the potential to
inform the ways in which decisions are made about timing of surgery
and information exchange around delay or cancellation. This may
inﬂuence satisfaction and outcome after hip replacement. We therefore
conducted a study to analyse how patients with osteoarthritis experi-
ence and conceptualise time as they wait for surgery.
Methods: A longitudinal, qualitative interview studywas conducted with
patients on a waiting list for total hip replacement. 111 patients were
approached to take part in in-depth interviews. Twenty-four patients
consented to participation and data saturation was achieved (13 men, 11
women, 52–82 years). Participants were interviewed at four time-points:
before surgery, two-four weeks, six months and 12 months afterwards.
Additional interviews were conducted when patients experienced delay
to their care pathway. Using a topic guide to aid questions, an experi-
enced qualitative researcher (EJ) interviewed participants about pain,
disability, views about surgery and pathways through healthcare. Inter-
views were audio-recorded, transcribed, anonymised and analysed using
inductive thematic analysis with double-coding by members of the
research team to ensure robust analysis and interpretation. Findings
presented here relate to the ﬁrst two time-points.
Results: Escalating pain and deterioration in function impacted on
patients’ experiences of time during their wait for hip replacement.
Participants made essential alterations to how they ﬁlled their days and
they experienced disruption to the passage of time in their lives. Tasks
tookmore time to accomplish and as participants had reduced activities
available to them, they reported a sense of time slowing down. Partic-
ipants’ lives were increasingly punctuated by activities relating to
managing their condition (e.g. regular use of pain medication) and
surgery (e.g. essential preparatory tasks). A surgical date marked in the
calendar became their focus. However, this date was not static: par-
ticipants described how they felt that the waiting time could feel slower
than time would normally pass, and the dates also shifted because of
hospitals’ alterations to surgery dates.
Conclusions: Internal factors (e.g. pain sensation, disability, constraints
on how time is spent) and external factors (e.g. preparatory tasks,
changes to surgery date) inﬂuenced participants’ experiences of time
while on the waiting list for hip replacement. However, the complexity
of participants’ perceptions of time during this period does not reﬂect
the linear, monochronic concept of time used by the healthcare system
and service providers. The study highlights a need to include discussion
about alterations made to daily life, pain management and expectations
of outcome in decisions to undergo hip replacement.
Funding: This poster presents independent research funded by the
National Institute for Health Research (NIHR) under its Programme
Grants for Applied Research programme (RP-PG-0407-10070). The
views expressed in this poster are those of the authors and not neces-
sarily those of the NHS, the NIHR or the Department of Health. The
research team acknowledge the support of the NIHR through the
Comprehensive Clinical Research Network.
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CURRENT EVIDENCE FOR CLINICAL PHENOTYPES IN KNEE
OSTEOARTHRITIS: A SYSTEMATIC REVIEW
M. Steultjens, R. Allan, S. Marreiros, S. Smith. Glasgow Caledonian Univ.,
Glasgow, United Kingdom
Purpose: Heterogeneity within the population of knee osteoarthritis
(KOA) patients impedes progress in our understanding of the disease
and development of effective interventions. It has been suggested that
distinct phenotypes, or patient subgroups characterised by distinctive
features, are present within the wider KOA population. The purpose of
this systematic review was to identify current evidence for the exis-
tence of distinct clinical phenotypes in KOA.
Methods: Literature databases were systematically searched for clinical
studies in humans with knee osteoarthritis aimed at subgroup or
phenotype identiﬁcation. Study quality was scored using a checklist for
observational studies according to STROBE guidelines.
Results: 19 full-text original papers were included in the review from
an initial search result of 625 abstracts. These studies addressed the
research areas of genetics; anatomy and medical imaging; bio-
chemistry; biomechanics; and epidemiology. Evidence was found for
the existence of an inﬂammatory phenotype linked to biomarkers such
